Host Susceptibility Factors to Bacterial Infections in Type 2 Diabetes

PLoS Pathogens

Volumn 9, Issue 12, 2013, Pages 1-3

  Gan, Yunn Hwen ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GAMMA INTERFERON; GLUCOSE; GLUTATHIONE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; HYDROGEN PEROXIDE; INTERLEUKIN 12; MEMBRANE PROTEIN; MEMBRANE PROTEIN FIMH; METFORMIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TRANSFERRIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL INFECTION; CHEMOTAXIS; DIABETIC FOOT; GLYCEMIC CONTROL; HOST SUSCEPTIBILITY; HUMAN; HYPERGLYCEMIA; IMMUNE RESPONSE; INNATE IMMUNITY; LIVER ABSCESS; MELIOIDOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PHAGOCYTOSIS; POLYMORPHONUCLEAR CELL; RESPIRATORY TRACT INFECTION; RISK FACTOR; TUBERCULOSIS; URINARY TRACT INFECTION; UROSEPSIS; ANIMAL; GLUCOSE BLOOD LEVEL; IMMUNOLOGY; MICROBIOLOGY; MOUSE; PHAGOCYTE; PHYSIOLOGY;

ANIMALS; BACTERIAL INFECTIONS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; HUMANS; IMMUNITY, INNATE; MICE; OXIDATIVE STRESS; PHAGOCYTES;

EID: 84892845427     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003794     Document Type: Article

References (33)

1. Dooley KE, Chaisson RE, (2009) Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 9: 737-746.
2. Bader MS, (2008) Diabetic foot infection. Am Fam Physician 78: 71-79.
3. Yano H, Kinoshita M, Fujino K, Nakashima M, Yamamoto Y, et al. (2002) Insulin treatment directly restores neutrophil phagocytosis and bactericidal activity in diabetic mice and thereby improves surgical site Staphylococcus aureus infection. Infect Immun 80: 4409-4416.
4. Hanses F, Park S, Rich J, Lee JC, (2011) Reduced neutrophil apoptosis in diabetic mice during Staphylococcal infection leads to prolonged Tnfα production and reduced neutrophil clearance. PLoS ONE 6: e23633 doi:10.1371/journal.pone.0023633.
5. Breen JD, Karchmer AW, (1995) Staphylococcus aureus infections in diabetic patients. Infect Dis Clin North Am 9: 11-24.
6. Jacobsson G, Dashti S, Wahlberg T, Andersson R, (2007) The epidemiology of and risk factors for invasive Staphylococcus aureus infections in western Sweden. Scand J Infect Dis 39: 6-13.
7. Skoff TH, Farley MM, Petit S, Craig AS, Schaffner W, et al. (2009) Increasing burden of invasive group B streptococcal disease in non-pregnant adults, 1990-2007. Clin Infect Dis 49: 85-92.
8. Lin YT, Wang FD, Wu PF, Fung CP, (2013) Klebsiella pneumoniae liver abscess in diabetic patients: association of glycemic control with the clinical characteristics. BMC Infect Dis 13: 56.
9. Geerlings SE, (2008) Urinary tract infections in patients with diabetes mellitus: epidemiology, pathogenesis and treatment. Int J Antimicrob Agents 31Suppl 1: 554-557.
10. Leung CC, Lam TH, Chan WM, Yew WW, Ho KS, et al. (2008) Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol 167: 1486-1494.
11. Pablos-Mendez A, BlusteinJ, Knirsch CA, (1997) The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Public Health 87: 574-579.
12. Leegaard A, Rus A, Kornum JB, Prahl JB, Tomsen VO, et al. (2011) Diabetes, glycemic control, and risk of tuberculosis. A population-based case-control study. Diabetes Care 34: 2530-2535.
13. Cheng AC, Currie BJ, (2005) Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 18: 383-416.
14. Chanchamroen S, Kewcharoenwong C, Susaengrat W, Ato M, Lertmemongkolchai G, (2009) Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects. Infect Immun 77: 456-63.
15. Riyapa D, Buddhisa S, Korbsrisate S, Cuccui J, Wren BW, et al. (2012) Neutrophil Extracellular Traps exhibit antibacterial activity against Burkholderia pseudomallei and are influenced by bacterial and host factors. Infect Immun 80: 3921-3929.
16. Gomez DI, Twahirwa M, Schlesinger LS, Restrapo BI, (2013) Reduced Mycobacterium tuberculosis association with monocytes from diabetes patients that have poor glucose control. Tuberculosis 93: 192-197.
17. Peleg AY, Weerarathna T, Macarthy JS, Davis TME, (2007) Common infections in diabetes: pathogenesis, management and relationship to glycemic control. Diabetes Metab Res Rev 23: 3-13.
18. Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Mechemias C, et al. (1982) Infection and diabetes: the case for glucose control. Am J Med 72: 439-450.
19. Rich J, Lee JC, (2005) The pathogenesis of Staphylococcus aureus infection in the diabetic NOD mouse. Diabetes 54: 2904-2910.
20. Tan KS, Lee KO, Low KC, Gamage AM, Liu Y, et al. (2012) Glutathione deficiency in Type 2 diabetes impairs cytokine responses and control of intracellular bacteria. J Clin Invest 122: 2289-2300.
21. Stegenga ME, van der Crabben SN, Blumer RME, Levi M, Meijers JCM, et al. (2008) Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood 112: 82-89.
22. Berhaus A, Hoffman MA, Ziegler R, Nawroth PP, (1998) AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res 37: 586-600.
23. Ilyas R, Wallis R, Soilleux EJ, Townsend P, Zehnder D, et al. (2010) High glucose disrupts oligosaccharide recognition function via competitive inhibition: A potential mechanism for immune dysregulation in diabetes mellitus. Immunobiology 216: 126-131.
24. Zwang TJ, Gormally MV, Johal MS, Sazinsky MH, (2012) Enhanced iron availability by protein glycation may explain higher infection rates in diabetics. Biometals 25: 237-245.
25. Collison KS, Parhar RS, Saleh SS, Meyer BF, Kwaasi AA, et al. (2002) RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs). J Leukoc Biol 71: 433-444.
26. Wang MC, Tseng CC, Wu AB, Lin WH, Ten CH, et al. (2013) Bacterial characteristics and glycemic control in diabetic patients with Escherichia coli urinary tract infection. J Microbiol Immunol Infect 46: 24-29.
27. Geerlings SE, Meiland R, van Lith EC, Brouwer EC, Gaastra W, et al. (2002) Adherence of type 1-fimbriated Escherichia coli to uroepithelial cells: more in diabetic women than in control subjects. Diabetes Care 25: 1405-1409.
28. Knight SD, Bouckaert J, (2009) Structure, function and assembly of the type 1 fimbraie. Top Curr Chem 288: 67-107.
29. Taganna J, de Boer AR, Wuhrer M, Bouckaert J, (2011) Glycosylation changes as important factors for the susceptibility to urinary tract infection. Biochem Soc Trans 39: 349-354.
30. Garnett JP, Baker EH, Naik S, Lindsay JA, Knight GM, et al. (2013) Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose. Thorax 68: 835-845.
31. Brownlee M, (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-20.
32. Koh GCKW, Schreiber MF, Bautista R, Maude RR, Dunachie S, et al. (2013) Host responses to melioidosis and tuberculosis are both dominated by interferon-mediated signalling. PLoS ONE 8: e54961 doi:10.1371/journal.pone.0054961.
33. Morris D, Khurasany M, Nguyen T, Kim J, Guikford F, et al. (2013) Glutathione and infection. Biochimie et Biophysica Acta 1830: 3329-3349.